Eurepa-V 0.5/0.2 Tablet
By Eurepa-V
Rx
10 Tablet in a Strip

Composition
Repaglinide(0.5mg) + Voglibose(0.2mg)

Manufacturer - Torrent Pharmaceuticals Ltd
Off. Ashram Road, Ahmedabad - 380 009., Gujarat, India

Expires on or after
November, 2026
About Eurepa-V 0.5/0.2 Tablet
Eurepa-V 0.5/0.2 Tablet 10's is a combination drug used in the treatment of Type 2 diabetes mellitus. This chronic condition leads to high blood sugar levels that can impact daily life, requiring dietary changes, medication, and regular monitoring. The tablet contains two active ingredients: Repaglinide and voglibose. Repaglinide stimulates the pancreas to release more insulin, regulating blood sugar levels, while voglibose inhibits an intestinal enzyme, delaying carbohydrate absorption. Together, they help prevent excessive blood sugar spikes after meals.
It is important to follow your doctor's instructions when taking Eurepa-V 0.5/0.2 Tablet 10's. The dosage is determined based on your medical condition and should be taken orally once daily in the morning. Consistency is key to experiencing the full benefits of the medication. Common side effects may include hypoglycemia, skin reactions, stomach pain, and diarrhea, which are usually temporary and do not require medical intervention.
Before starting Eurepa-V 0.5/0.2 Tablet 10's, inform your healthcare provider about any allergies or existing conditions, especially kidney or liver problems. Pregnant or breastfeeding individuals should consult their doctor before taking this medication. It is vital not to discontinue the treatment without medical advice, as sudden cessation can lead to uncontrolled blood sugar levels, putting you at risk of complications like kidney damage or vision impairment.
Regular monitoring of blood sugar levels is recommended while on this medication. If you experience persistent side effects or your condition does not improve, consult your doctor. Additionally, avoid excessive alcohol consumption while taking Eurepa-V 0.5/0.2 Tablet 10's, as it may exacerbate certain side effects. Remember that this tablet is just one component of a comprehensive treatment plan that includes a healthy diet, regular exercise, and weight management as advised by your doctor.
Benefits
Eurepa-V 0.5/0.2 Tablet is a valuable medication used in the treatment of Type 2 diabetes mellitus. This medication plays a crucial role in controlling high blood glucose levels, aiding in the management of diabetes. By assisting in the removal of excess glucose through urine, Eurepa-V 0.5/0.2 Tablet helps to regulate blood sugar levels effectively. Additionally, it works by slowing down the breakdown of food in the intestine, thereby reducing the rapid increase in blood sugar levels after meals. This ability to lower blood glucose levels is essential in preventing serious complications associated with diabetes, such as kidney damage, eye damage, nerve issues, and even the potential loss of limbs. Importantly, Eurepa-V 0.5/0.2 Tablet can also lower the risk of death from cardiovascular disease for individuals with Type 2 diabetes who already have cardiovascular issues. By incorporating this medication into a daily routine alongside a proper diet and exercise regimen, individuals can greatly improve their quality of life and reduce the chances of experiencing severe health complications. It is recommended to adhere to the prescribed usage of Eurepa-V 0.5/0.2 Tablet in order to safeguard and support future health outcomes, enabling individuals to lead normal and healthy lives.
How to use the Eurepa-V 0.5/0.2 Tablet
To use Eurepa-V 0.5/0.2 Tablet effectively, always follow your doctor's instructions on dosage and duration. Remember to swallow the tablet whole with a glass of water. It is essential to take Eurepa-V 0.5/0.2 Tablet with food. Avoid chewing, crushing, or breaking the tablet as it may alter its effectiveness. Your physician will determine the suitable dose and duration based on factors such as your age, weight, and specific health condition. Trust your doctor's guidance to ensure you are using Eurepa-V 0.5/0.2 Tablet properly for optimal results.
Uses of Eurepa-V 0.5/0.2 Tablet
Eurepa-V 0.5/0.2 Tablet is used in the treatment of Type 2 diabetes mellitus. It is specifically meant to be an adjunct along with diet and exercise to help manage Type 2 diabetes mellitus in individuals affected by this condition. This medication works by helping to control blood sugar levels in the body. It is important to follow a healthy diet and exercise regimen while using Eurepa-V 0.5/0.2 Tablet to achieve the best results in managing Type 2 diabetes mellitus.
What conditions Eurepa-V 0.5/0.2 Tablet treats?
Eurepa-V 0.5/0.2 Tablet is used to treat type 2 diabetes mellitus by helping to control high blood sugar levels. It works after meals to lower blood sugar when other medicines and diet restrictions are not enough. Maintaining blood sugar levels reduces risks of kidney damage, blindness, and other serious complications of diabetes. Regular use, along with a healthy lifestyle, can help manage diabetes effectively and improve long-term health outcomes. It is important to follow your doctor's instructions and not stop the medication abruptly to avoid potential risks.
Should you consult a doctor?
Seek immediate medical attention and consult your doctor if you have type 1 diabetes, diabetic ketoacidosis, or severe infections before or after an operation, as the use of Eurepa-V 0.5/0.2 Tablet is not recommended in such cases. It is also vital to inform your doctor if you are scheduled for major surgery, have recently experienced a severe illness, or are currently dealing with fever, trauma, or infection. Additionally, individuals with a history of laparotomy or ileus, chronic intestinal diseases affecting digestion, or gastrointestinal obstruction should consult a healthcare professional before taking this medication to ensure its safe and effective use. Early communication with your doctor can help in assessing the suitability of Eurepa-V 0.5/0.2 Tabletfor your specific medical condition and prevent any potential risks.
Side effects of Eurepa-V 0.5/0.2 Tablet
When taking Eurepa-V 0.5/0.2 Tablet, some individuals may experience certain side effects. Most of these side effects are usually mild and transient as your body gets used to the medication. However, if these side effects persist or cause concern, it is crucial to consult your doctor for guidance.
One common side effect of Eurepa-V 0.5/0.2 Tablet is hypoglycemia, which refers to low blood glucose levels. Signs of hypoglycemia may include a rapid heart rate, shaking, and sweating. Additionally, abdominal pain, diarrhea, flatulence, and headaches are among the potential side effects reported by some individuals taking this medication.
Moreover, individuals may experience abdominal pain or discomfort, diarrhea, and signs of gastritis, such as upper abdomen pain, nausea, and vomiting. Swelling of the face, arms, or legs, headache, fever, sore throat, sinusitis, muscle pain, and tenderness are also listed as potential side effects of Eurepa-V 0.5/0.2 Tablet. In rare cases, more severe side effects like acute coronary syndrome, anemia, thrombocytopenia (low platelet level), and leucopenia (low white blood cell count) may occur.
If you notice any signs of an allergic reaction, such as swelling, difficulty in breathing, rapid heartbeat, dizziness, or sweating, it is crucial to stop taking the medication immediately and contact your doctor. Additionally, signs of a skin hypersensitivity reaction, like erythema, itching, rashes, or itchy welts, should be reported to your healthcare provider promptly.
Remember, everyone may react differently to medications, and it is essential to be aware of potential side effects while taking Eurepa-V 0.5/0.2 Tablet. If you have any concerns or experience any of the mentioned side effects, seeking medical advice is advisable for appropriate management.
Safety advice

liver
Eurepa-V 0.5/0.2 Tablet should be used carefully in patients with liver disease. It may be necessary to adjust the dose of Eurepa-V 0.5/0.2 Tablet in such cases. It is important to consult your doctor before using this medication to ensure it is safe and appropriate for your liver condition.

kidney
Eurepa-V 0.5/0.2 Tablet requires caution in severe kidney disease. Dosage adjustment may be necessary. Consult your doctor for guidance.

alcohol
It is not safe to drink alcohol while taking Eurepa-V 0.5/0.2 Tablet.

driving
When taking Eurepa-V 0.5/0.2 Tablet, avoid driving if experiencing low or high blood sugar symptoms to prevent impairment while driving.

pregnancy
Eurepa-V 0.5/0.2 Tablet may not be safe to use during pregnancy. Animal studies indicate potential harm to the developing baby. Consult your doctor to evaluate the benefits and risks before taking this medication during pregnancy.

breastfeeding
Eurepa-V 0.5/0.2 Tablet is likely unsafe during breastfeeding. Limited data indicates it may pass into breastmilk and harm the baby.
Age above 75(Geriatrics)
Eurepa-V 0.5/0.2 Tablet is not recommended for use in elderly patients (aged above 75 years). Consult and inform your doctor before taking Eurepa-V 0.5/0.2 Tablet.
Age below 6 months(Pediatrics)
Eurepa-V 0.5/0.2 Tablet is not recommended for use in children and adolescents (aged below 18 years). Consult and inform your doctor before taking Eurepa-V 0.5/0.2 Tablet.
Consumption warning before consuming Eurepa-V 0.5/0.2 Tablet
Before taking Eurepa-V 0.5/0.2 Tablet, it is crucial to follow certain precautions. This medication is typically used for treating type 2 diabetes mellitus by controlling high blood sugar levels post meals. Always take this tablet immediately after meals, as prescribed by your doctor. Do not stop taking it abruptly without consulting your doctor, as it could lead to a spike in blood sugar levels, putting you at risk of severe complications such as kidney damage and vision problems. If you miss a dose, do not double up on the next dose; instead, wait until your next scheduled meal and take it as usual.
Common side effects of Eurepa-V 0.5/0.2 Tablet may include flatulence, diarrhea, stomach pain, hypoglycemia, and skin rash. Monitor your blood sugar levels regularly while using this medicine. In case these side effects persist or worsen, seek advice from your healthcare provider. Inform your doctor about any existing kidney or liver issues, urinary tract infections, or if you are taking diuretics. Pregnant or nursing women should consult a healthcare professional before starting this medication. Limit alcohol consumption to minimize the risk of certain side effects.
What if you forgot to take Eurepa-V 0.5/0.2 Tablet?
If you forget to take a dose of Eurepa-V 0.5/0.2 Tablet, take it as soon as you remember. But if it's almost time for your next dose, don't take the missed one. Just continue with your normal dosing schedule. Never take a double dose to make up for the missed one.
What happens if you take overdose of Eurepa-V 0.5/0.2 Tablet?
If too much of Eurepa-V 0.5/0.2 Tablet is taken by mistake, urgent action is required. Contact your doctor right away or go to the nearest hospital. An overdose can lead to hypoglycemia, which shows symptoms like dizziness, sweating, tremors, headaches, loss of consciousness, seizures, and even coma. It's crucial to seek immediate medical help in case of an overdose.
Related lab tests
For monitoring the effects of Eurepa-V 0.5/0.2 Tablet on your body, your healthcare provider may recommend several related lab tests. These tests can help assess how well your body is managing blood sugar levels. The first test is Glucose - Fasting Blood, which measures your blood sugar levels after fasting for at least 8 hours. The second test is Glucose - Postprandial Blood, which checks your blood sugar levels 2 hours after eating. Lastly, Glycosylated Hemoglobin test provides an average of your blood sugar levels over the past 2-3 months. These lab tests are crucial in monitoring your response to medication and ensuring your blood sugar levels are within the desired range.
Additional Information
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI DIABETIC |
Action Class | - |
FAQs
Disclaimer
The information provided on this website is to the best of our abilities to ensure it is accurate, reliable, and reviewed by a team of professionals. It should not be used to diagnose, prevent, or cure any health problem. The information presented here is not intended to create a doctor-patient relationship or replace a registered medical practitioner's advice, diagnosis, or treatment. The absence or provision of any information or warning regarding any medicine should not be assumed as an implied or explicit assurance of safety or efficacy. We highly recommend consulting your registered medical practitioner for all queries or doubts related to your medical condition. Do not ignore professional medical advice or delay seeking it based on the content encountered on our website. We intend to support, not replace, the doctor-patient relationship.
₹155
Inclusive of all taxes
Content verified by

Dr. Upasana Bhatia
MBBS - General Medicine
Last update on 01-Oct-2024